
Novel alkylphospholipid-DTC hybrids as promising agents against endocrine related cancers acting via modulation of Akt-pathway
Keywords: Alkylphospholipid; Dithiocarbamate; Akt-pathway; Endocrine cancer; Miltefosine; Anti-proliferative agentAPCs, alkylphosphocholines; DDTC, diethyldithiocarbamate; HEK, human embryonic kidney; PI, propidium iodide; MMP, mitochondrial membrane potential; ATC